首页> 外文期刊>Bone marrow transplantation >Double umbilical cord blood transplantation in patients with hematologic malignancies using a reduced-intensity preparative regimen without antithymocyte globulin
【24h】

Double umbilical cord blood transplantation in patients with hematologic malignancies using a reduced-intensity preparative regimen without antithymocyte globulin

机译:降低强度的无抗胸腺细胞球蛋白的制备方案在血液系统恶性肿瘤患者中进行双脐血移植

获取原文
获取原文并翻译 | 示例
           

摘要

Reduced-intensity conditioning (RIC) regimens in cord blood transplant (CBT) are increasingly utilized for older patients and those with comorbidities. However, the optimal conditioning regimen has not yet been established and remains a significant challenge of this therapeutic approach. Antithymocyte globulin (ATG) has been incorporated into conditioning regimens in order to decrease the risk of graft failure; however, use of ATG is often associated with infusion reactions and risk of post-transplant complications. We report the results of a non-ATG-containing RIC regimen, where patients received 2 Gy TBI unless they were considered to be at higher risk of graft failure, in which case they received 3 Gy of TBI. Thirty patients underwent CBT using this protocol for high-risk hematological malignancies. There was only one case of secondary and no cases of primary graft failure. At 1 year, estimates of non-relapse mortality, OS and PFS were 29%, 53% and 45%, respectively. The cumulative incidences of grade III-IV acute and chronic GVHD were 14% and 18%, respectively. In summary, the results of this study demonstrate that this non-ATG-containing conditioning regimen provides a low incidence of graft failure without increasing regimen-related toxicity.
机译:脐带血移植(CBT)中的降低强度调节(RIC)方案越来越多地用于老年患者和合并症患者。然而,最佳的调节方案尚未建立,并且仍然是该治疗方法的重大挑战。为了降低移植失败的风险,抗胸腺细胞球蛋白(ATG)已被纳入调理方案中。但是,ATG的使用通常与输液反应和移植后并发症的风险有关。我们报告了不包含ATG的RIC方案的结果,其中患者接受2 Gy TBI,除非他们被认为有更高的移植失败风险,在这种情况下,他们接受3 Gy TBI。 30例使用此方案治疗高危血液恶性肿瘤的CBT患者。只有一例继发性继发性移植失败。在1年时,非复发死亡率,OS和PFS的估计分别为29%,53%和45%。 III-IV级急性和慢性GVHD的累积发生率分别为14%和18%。总而言之,这项研究的结果表明,这种不含ATG的调理方案在不增加与方案相关的毒性的情况下,移植失败率低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号